Updating results

1681 results

Sort: Relevance | Date

Asthma: fluticasone/formoterol (Flutiform) combination inhaler (ESNM3)

Summary of the evidence on fluticasone/formoterol (Flutiform) combination inhaler for treating asthma to inform local NHS planning and decision-making

Evidence summary Published October 2012

Partial-onset seizures in epilepsy: zonisamide as monotherapy (ESNM17)

Summary of the evidence on zonisamide as monotherapy for children and young people with epilepsy to inform local NHS planning and decision-making

Evidence summary Published April 2013

Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab (ESNM13)

Summary of the evidence on subcutaneous trastuzumab for HER2-positive breast cancer to inform local NHS planning and decision-making

Evidence summary Published March 2013

ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)

Advice on the use of ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot to aid local decision-making

Medtech innovation briefing Published March 2016

AccuVein AV400 for vein visualisation (MIB6)

Advice on the use of AccuVein AV400 for vein visualisation (peripheral venous access) to aid local decision-making

Medtech innovation briefing Published June 2014

The Space GlucoseControl system for managing blood‑glucose in critically ill patients in intensive care (MIB17)

Advice on the use of the Space GlucoseControl system for managing blood-glucose in critically ill patients in intensive care to aid local decision-making

Medtech innovation briefing Published December 2014

The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (MIB18)

Advice on the use of AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (CPR) to aid local decision-making

Medtech innovation briefing Published February 2015

Pre-exposure prophylaxis of HIV in adults at high risk: Truvada (emtricitabine/tenofovir disoproxil) (ESNM78)

Summary of the evidence on Truvada (emtricitabine/tenofovir disoproxil) for pre-exposure prophylaxis (PrEP) of HIV in adults at high risk

Evidence summary Published October 2016

Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)

Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

Evidence summary Published May 2016

Premature ejaculation: dapoxetine (ESNM40)

Summary of the evidence on dapoxetine for premature ejaculation to inform local NHS planning and decision-making

Evidence summary Published May 2014

Skin involvement in systemic sclerosis: rituximab (ES7)

Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making

Evidence summary Published March 2017

The NGAL Test for early diagnosis of acute kidney injury (MIB3)

Advice on the use of the NGAL Test for early diagnosis of acute kidney injury (AKI) to aid local decision-making

Medtech innovation briefing Published February 2014

Episcissors-60 for guided mediolateral episiotomy (MIB33)

Advice on the use of the Episcissors-60 for guided mediolateral episiotomy to aid local decision-making

Medtech innovation briefing Published July 2015

Visensia for early detection of deteriorating vital signs in adults in hospital (MIB36)

Advice on the use of the Visensia for early detection of deteriorating vital signs in adults in hospital to aid local decision-making

Medtech innovation briefing Published August 2015

i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

Advice on the use of the i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department to aid local decision-making

Medtech innovation briefing Published September 2015

PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)

Advice on the use of the PROPATEN heparin-bonded vascular graft for treating peripheral arterial disease to aid local decision-making

Medtech innovation briefing Published October 2015

The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)

Advice on the use of the hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability to aid local decision-making

Medtech innovation briefing Published August 2014

Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)

Advice on the use of the Alair bronchial thermoplasty system for treating adults with severe, difficult to control asthma to aid local decision-making

Medtech innovation briefing Published July 2016

Stretta System for gastro-oesophageal reflux disease (MIB74)

Advice on the use of Stretta System for gastro-oesophageal reflux disease (GORD)

Medtech innovation briefing Published July 2016

OSNA for colon cancer staging (MIB77)

Advice on the use of OSNA in vitro diagnostic molecular assay system for staging colon cancer to aid local decision-making

Medtech innovation briefing Published August 2016

The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma (MIB8)

Advice on the use of the Airsonett temperature-controlled laminar airflow device for persistent allergic asthma to aid local decision-making

Medtech innovation briefing Published August 2014

Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)

ES12 Non-cystic fibrosis bronchiectasis: inhaled tobramycin Key points

Evidence summary Published April 2017

Type 1 diabetes: insulin degludec (ESNM24)

Summary of the evidence on insulin degludec for treating type 1 diabetes to inform local NHS planning and decision-making

Evidence summary Published September 2013

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Antimicrobial prescribing: Ceftazidime/avibactam (ES16)

Summary of the evidence on ceftazidime/avibactam for complicated intra-abdominal and UTI infections and hospital-acquired pneumonia

Evidence summary: antimicrobial prescribing Published November 2017

HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (MIB128)

Advice on the use of HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published November 2017

Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)

Summary of the evidence on beclometasone, formoterol and glycopyrronium (Trimbow) for chronic obstructive pulmonary disease (COPD) to inform local NHS planning

Evidence summary Published May 2018

RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

Advice on the use of point-of-care (POC) creatinine tests for measuring kidney function before contrast-enhanced imaging to aid local decision-making

Medtech innovation briefing Published January 2018

EpiFix for chronic wounds (MIB139)

Advice on the use of EpiFix (an allograft comprising dehydrated human amnion/chorion membrane tissue/dHACM) for chronic wounds to aid local decision-making

Medtech innovation briefing Published January 2018

Non-steroidal anti-inflammatory drugs (KTT13)

KTT13 Non-steroidal anti-inflammatory drugs Options for local implementation Review

Key therapeutic topic Published January 2015 Last updated February 2018

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

Caris Molecular Intelligence for guiding cancer treatment (MIB120)

Advice on the use of Caris Molecular Intelligence (CMI; solid tumour biomarker analysis service) for guiding cancer treatment to aid local decision-making

Medtech innovation briefing Published September 2017

myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

Advice on the use of myAIRVO2 (warms and humidifies respiratory gases) for treating chronic obstructive pulmonary disease (COPD) to aid local decision-making

Medtech innovation briefing Published October 2018

FLEXISEQ for osteoarthritis (MIB80)

Advice on the use of FLEXISEQ for treating the symptoms of osteoarthritis to aid local decision-making

Medtech innovation briefing Published September 2016

The V.A.C. Veraflo Therapy system for infected wounds (MIB189)

Advice on the use of the V.A.C. Veraflo Therapy system for infected wounds to aid local decision making

Medtech innovation briefing Published September 2019

NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)

Advice on the use of NephroCheck test (Ortho Clinical Diagnostics) to help assess acute kidney injury risk in critically ill patients to aid local decision

Medtech innovation briefing Published August 2018

Complicated urinary tract infections: ceftolozane/tazobactam (ESNM74)

Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)

Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Moderate to severe acute post­-operative pain: sufentanil sublingual tablet system (ESNM71)

Summary of the evidence on the sufentanil sublingual tablet system for treating post­operative pain to inform local NHS planning and decision-making

Evidence summary Published March 2016

Chronic wounds: advanced wound dressings and antimicrobial dressings (ESMPB2)

Summary of the evidence on advanced wound dressings and antimicrobial dressings for managing chronic wounds to inform local NHS planning and decision-making

Evidence summary Published March 2016

eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)

Advice on the use of eazyplex SuperBug kits for detecting carbapenemase-producing organisms (bacteria) to aid local decision-making

Medtech innovation briefing Published February 2017

Smartinhaler for asthma (MIB90)

Advice on the use of Smartinhaler for monitoring the activation of asthma inhalers to aid local decision-making

Medtech innovation briefing Published January 2017

Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

Advice on the use of the Alere Afinion CRP for C-reactive protein testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

Otovent nasal balloon for otitis media with effusion (MIB59)

Advice on the use of the Otovent nasal balloon for relieving the symptoms of otitis effusion (glue ear) to aid local decision-making

Medtech innovation briefing Published March 2016

Lutonix drug-coated balloon for peripheral arterial disease (MIB72)

Advice on the use of Lutonix drug-coated balloon (DCB; Lutonix 035) for treating peripheral arterial disease (PAD) to aid local decision-making

Medtech innovation briefing Published July 2016

QuikRead go for C-reactive protein testing in primary care (MIB78)

Advice on the use of QuickRead go for C-reactive protein (CRP) testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

Biosimilar medicines (KTT15)

KTT15 Biosimilar medicines Options for local implementation Biosimilar medicines have

Key therapeutic topic Published February 2016 Last updated February 2018

Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)

Advice on the use of Woundchek Protease Status for assessing elevated protease status in chronic wounds to aid local decision-making

Medtech innovation briefing Published October 2016

Needle-free arterial non-injectable connector (MIB85)

Advice on the use of needle-free arterial non-injectable connector through which blood samples can be collected to aid local decision-making

Medtech innovation briefing Published October 2016